-
From the Editor-in-Chief
Palliative Care: Putting a Cloak on CancerPatients should have access to this vital and emerging medical specialty.
by William G. Nelson, MD, PhD
-
But I Already Have CancerFor a patient with advanced cancer, how important is screening for other types of cancer?
by Ide Mills
-
Forward Look
The Impact of Rising Drug CostsHigher prices of oral medicines may affect financial well-being.
by Chris Palmer
-
Your Cancer Guide
Ways to Find Meaning in LifeA cancer diagnosis can prompt survivors to question or deepen their faith.
by Hester Hill Schnipper
-
Caregiving With Confidence
Being a Parent While Caring for OneTake these steps to delegate responsibilities and strike a balance.
by Liz Seegert
-
First Person
How To Be An Effective Cancer EducatorA breast cancer survivor recounts how she became a resource for others.
by Cynthia Ryan
-
Q&A
Cooking Through CancerCancer survivor Ann Ogden Gaffney left her job in fashion to teach other cancer survivors how to cook.
by Kate Yandell
-
Sound Advice
Winter 2016/2017vol 06 | issue 04
Coping with a difficult parent, sexual activity during treatment, and talking with children about inheritable cancers. -
Forward Look
Addressing Depression in Adult Cancer SurvivorsStudy links depression to money woes and missed opportunities for follow-up.
by Marilyn Fenichel
-
Sound Advice
Fall 2016vol 06 | issue 03
Anxiety about cellphones and cancer, crowdfunding to help pay the bills, and the side effects of steroids.
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
